ORNL’s electromagnetic isotope separator, or EMIS, made history in 2018 when it produced 500 milligrams of the rare isotope ruthenium-96, unavailable anywhere else in the world.
Growing up in suburban Upper East Tennessee, Layla Marshall didn’t see a lot of STEM opportunities for children.
“I like encouraging young people to get involved in the kinds of things I’ve been doing in my career,” said Marshall. “I like seeing the students achieve their goals. It’s fun to watch them get excited about learning new things and teaching the robot to do things that they didn’t know it could do until they tried it.”
Marshall herself has a passion for learning new things.
A series of new classes at Pellissippi State Community College will offer students a new career path — and a national laboratory a pipeline of workers who have the skills needed for its own rapidly growing programs.
With larger, purer shipments on a more frequent basis, Oak Ridge National Laboratory is moving closer to routine production of promethium-147. That’s thanks in part to the application of some specific research performed a decade ago for a completely different project.
Three scientists from the Department of Energy’s Oak Ridge National Laboratory have been elected fellows of the American Association for the Advancement of Science, or AAAS.
Several significant science and energy projects led by the ORNL will receive a total of $497 million in funding from the Inflation Reduction Act.
U.S. Secretary of Energy Jennifer Granholm visited Oak Ridge National Laboratory today to attend a groundbreaking ceremony for the U.S. Stable Isotope Production and Research Center. The facility is slated to receive $75 million in funding from the Inflation Reduction Act.
Researchers at ORNL explored radium’s chemistry to advance cancer treatments using ionizing radiation.
Two decades in the making, a new flagship facility for nuclear physics opened on May 2, and scientists from the Department of Energy’s Oak Ridge National Laboratory have a hand in 10 of its first 34 experiments.
In experiment after experiment, the synthetic radioisotope actinium-225 has shown promise for targeting and attacking certain types of cancer cells.